Underlying aetiology of pulmonary hypertension in 191 patients: A single centre experience

Respirology

Volumn 13, Issue 6, 2008, Pages 825-831

  Fruchter, Oren ^a   Yigla, Mordechai ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Division of Pulmonary Medicine   (Israel)

Author keywords

Aetiology; Epidemiology; Pulmonary hypertension

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; DOPPLER ECHOCARDIOGRAPHY; ECONOMIC ASPECT; FEMALE; HEART CATHETERIZATION; HEMATOLOGIC DISEASE; HEMODIALYSIS; HUMAN; IDIOPATHIC DISEASE; LIVER CIRRHOSIS; LUNG ALVEOLUS HYPOVENTILATION; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; THROMBOEMBOLISM; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; YOUNG ADULT;

EID: 51349135059     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01364.x     Document Type: Article

References (21)

1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W et al. Clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2004 16 : S5 12.
2. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N. Engl. J. Med. 2004 351 : 1655 65.
3. Rubin LJ, Badesch DB. Evaluation and management of the patient with pulmonary arterial hypertension. Ann. Intern. Med. 2005 143 : 282 92.
4. Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur. Respir. J. 2003 21 : 892 905.
5. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005 172 : 189 94.
6. Rodriguez-Roisin R, Krowka MJ, Fallon MB. Pulmonary-hepatic vascular disorders. Eur. Respir. J. 2004 24 : 861 80.
7. Mehta S, Little S. Screening for pulmonary hypertension in scleroderma: how and when to look? J. Rheumatol. 2006 33 : 204 6.
8. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001 120 : 801 8.
9. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation 2006 113 : 2011 20.
10. Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest 2004 126 : 420 7.
11. Stricker H, Domenighetti G, Popov W, Speich R, Nicod L et al. Severe pulmonary hypertension: data from the Swiss Registry. Swiss Med. Wkly. 2001 16 : 346 50.
12. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G et al. Pulmonary arterial hypertension in France: results from a national registry. Am. J. Respir. Crit. Care Med. 2006 173 : 1023 30.
13. Yigla M, Dabbah S, Azzam ZS, Rubin AH, Reisner SA. Background diseases in 671 patients with moderate to severe pulmonary hypertension. Isr. Med. Assoc. J. 2000 2 : 684 9.
14. Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005 127 : 1836 43.
15. Mukerjee D, St George D, Knight C, Davar J, Wells AU et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004 43 : 461 6.
16. Naeiji R, Torbicki A. More on the non-invasive diagnosis of pulmonary hypertension: doppler echocardiography revisited. Eur. Respir. J. 1995 8 : 1445 9.
17. Bakst AE, Gaine SP, Rubin LJ. Continuous intravenous epoprostenol therapy for pulmonary hypertension in Gaucher's disease. Chest 1999 116 : 1127 9.
18. Yigla M, Kramer MR, Bendayan D, Reisner SA, Solomonov A. Unexplained severe pulmonary hypertension in the elderly: report on 14 patients. Isr. Med. Assoc. J. 2004 6 : 78 81.
19. Abassi Z, Nakhoul F, Khankin E, Reisner SA, Yigla M. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective. Curr. Opin. Nephrol. Hypertens 2006 15 : 353 60.
20. Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol. Dial. Transplant. 2005 20 : 1686 92.
21. Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B et al. Pulmonary hypertension in patients with end-stage renal disease. Chest 2003 123 : 1577 82.